Historical Stock Returns for Gland Pharma ScanXNewsGland Pharma Projects Growth Through Capacity Expansion and Product Diversification Gland Pharma Reports 12% Increase in Q2 Net Profit, Revenue Grows 5.8% 2 min read Updated on 03 Nov 2025, 04:46 PM Reviewed by Riya DScanX News Team AI Summary Gland Pharma Limited announced its Q2 FY2024 results, showing significant growth
Of these, around 20,000 had been prescribed glucagon-like peptide-1 (GLP-1) receptor agonists
Side effects are rare and typically mild, such as slight tingling or temporary redness after application
Endogenous glutathiones harboring either all 12 C or one 13 C in samples, which were collected before the ingestion of glutathione-1- 13 C, were determined
To function correctly, they need to be able to proliferate and communicate quickly